AETN 8-K
Aeternum Health, Inc. (AETN)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
(Exact name of registrant as specified in our charter)
(State of other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s
telephone number, including area code:
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| OTC ID |
Emerging
growth company
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| Item 1.01 | Entry into a Material Definitive Agreement. |
On August 7, 2026, the registrant, Aeternum Health, Inc. (“Aeternum” or the “Company”) initiated its entry to the mining and production of critical minerals by acquiring the option held by Manaslu LLC to purchase a 50.1% stake in American Renaissance Materials LLC to acquire the Nkamouna Nickel-Cobalt mining project in Cameroon, which is more fully described in Appendix I to the Asset Purchase Agreement, for 50,000,000 shares of the Company’s common stock and 2,000,000 shares of its Series B preferred stock. The foregoing description of the Asset Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the agreement that is attached as Exhibit 10.1 hereto and incorporated herein by reference.
Item 3.02. Unregistered Sales of Equity Securities.
The matters described in Item 1.01 of this Current Report on Form 8-K are incorporated herein by reference.
Item 7.01 Regulation FD Disclosures.
On August 7, 2026, the Company issued a press release regarding the purchase of the option from Manaslu LLC described in Item 1.01 of this Current Report on Form 8-K. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.
In accordance with General Instruction B.2 of this Current Report on Form 8-K, the information in this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by Laser Photonics that the information contained herein, including the exhibits hereto, is material or that the dissemination of such information is required by Regulation FD.
Item 9.01 Financial Statements and Exhibits.
| Exhibits | ||
| 10.1 | Asset Purchase Agreement dated August 7, 2026, between Aeternum Health, Inc. and Manaslu LLC | |
| 99.1 | Press Release issued August 7, 2026 | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this Form 10 to be signed on our behalf by the undersigned, thereunto duly authorized.
| Date: August 13, 2026 | AETERNUM HEALTH, INC. | |
| By: | /s/ Paul Mann | |
| Name: | Paul Mann | |
| Title: | President | |
Exhibit 10.1
ASSET PURCHASE AGREEMENT
This Asset Purchase Agreement (this “Agreement”) is made as of August 7, 2026, by and between Aeternum Health, Inc., a Delaware corporation (the “Company”), and Manaslu LLC (“Seller”).
A. The Seller is the owner of an option to acquire a 50.1% stake in American Renaissance Materials LLC (“ARM”), and the Company desires to acquire this asset, which is more fully described in Appendix I to Exhibit A hereto (the “Assets”), in full consideration of which the Company will issue shares of its Series B preferred stock, par value $0.01 per share (“Preferred Stock”) and its shares of common stock, par value $0.01 per share (“Common Stock”) to the Seller.
B. Seller desires to sell to the Company the Assets for the equity consideration set forth in this Agreement.
NOW, THEREFORE, in consideration for the mutual promises and covenants set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:
1. Number of Shares and Consideration. Subject to the terms and conditions of this Agreement, the Seller hereby agrees to sell the Assets to the Company in return for the Company agreeing to issue to the Seller 50,000,000 shares of Common Stock and 2,000,000 shares of Series B Preferred Stock (collectively, the “Shares”) . The consideration for the Shares will be the Seller’s transfer to the Company of all of the Seller’s rights in the Assets. Seller agrees to execute and deliver the form of Bill of Sale attached hereto as Exhibit A and such other documents as the Company may from time to time request to confirm such transfer. The closing of such purchase shall occur immediately upon execution of this Agreement.
2. Legends. All certificates representing any of the Shares subject to the provisions of this Agreement shall have endorsed thereon the following legends:
(a) “THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT COVERING SUCH SECURITIES, THE SALE IS MADE IN ACCORDANCE WITH RULE 144 UNDER THE ACT, OR THE COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF THESE SECURITIES REASONABLY SATISFACTORY TO THE COMPANY, STATING THAT SUCH SALE, TRANSFER, ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE ACT.”
(b) Any legend required to be placed thereon under applicable state securities laws.
3. Representations and Warranties. In connection with the proposed purchase of the Shares, the Seller hereby agrees, represents and warrants as follows:
(a) The Seller is purchasing the Shares solely for the Seller’s own account for investment and not with a view to, or for resale in connection with, any distribution thereof within the meaning of the Securities Act.
(b) The Seller realizes that Seller’s purchase of the Shares will be a highly speculative investment, and Seller is able, without impairing Seller’s financial condition, to hold the Shares for an indefinite period of time and to suffer a complete loss of Seller’s investment.
(c) The Company has disclosed to the Seller that:
(i) The sale of the Shares has not been registered under the Securities Act, and the Shares must be held indefinitely unless a transfer of it is subsequently registered under the Securities Act or an exemption from such registration is available, and that the Company is under no obligation to register the Shares;
(ii) The Company will make a notation in its records of the aforementioned restrictions on transfer and legends.
(d) The Seller is aware of the provisions of Rule 144 promulgated under the Securities Act, which, in substance, permits limited public resale of “restricted securities” acquired, directly or indirectly, from the issuer thereof (or an affiliate of such issuer), in a non-public offering subject to the satisfaction of certain conditions, including among other things: the resale occurring not less than six (6) months from the date the Seller has purchased and paid for the Shares; the availability of certain public information concerning the Company; the sale being through a broker in an unsolicited “broker’s transaction” or in a transaction directly with a market maker; and limitations on the amount of Shares that may be sold during any three (3) month period. The Seller further represents that Seller understands that at the time Seller wishes to sell the Shares there may be no public market upon which to make such a sale, and that, even if such a public market then exists, the Company may not be satisfying the current public information requirements of Rule 144, and that, in such event, the Seller would be precluded from selling the Shares under Rule 144 even if the six (6) month minimum holding period had been satisfied.
(e) Without in any way limiting the Seller’s representations and warranties set forth above, the Seller further agrees that the Seller shall in no event make any disposition of all or any portion of the Shares which the Seller is purchasing unless and until:
(i) There is then in effect a Registration Statement under the Securities Act covering such proposed disposition and such disposition is made in accordance with said Registration Statement; or
(ii) The Seller shall have (1) notified the Company of the proposed disposition and furnished the Company with a detailed statement of the circumstances surrounding the proposed disposition, and (2) if reasonably requested by the Company, furnished the Company with an opinion of counsel to the effect that such disposition will not require registration of such shares under the Securities Act.
4. Transfers in Violation of Agreement. The Company shall not be required to (a) transfer on its books any of the Shares which shall have been sold or transferred in violation of any of the provisions set forth in this Agreement or (b) treat as owner of such shares or to accord the right to vote as such owner or to pay dividends to any transferee to whom such shares shall have been so transferred.
5. Miscellaneous.
(a) Further Instruments. The parties agree to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement.
(b) Notice. All notices required or permitted hereunder shall be in writing and shall be deemed effectively given (i) upon personal delivery, (ii) when sent by confirmed electronic mail or facsimile, if sent during normal business hours of recipient, or if not, then on the next business day, or (iii) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the party to be notified at the address as set forth on the signature pages hereof or at such other address as such party may designate by ten (10) days advance written notice to the other parties hereto.
| 2 |
(c) Successors and Assigns. This Agreement shall inure to the benefit of the successors and assigns of the Company and, subject to the restrictions on transfer herein set forth, be binding upon the Seller and the Seller’s heirs, executors, administrators, successors and assigns.
(d) Applicable Law. This Agreement, together with the exhibits hereto, shall be governed by and construed in accordance with the laws of the State of Delaware regardless of the laws that might otherwise govern under principles of conflict of laws applicable thereto.
(e) Entire Agreement. This Agreement and the exhibits attached hereto constitute the entire agreement of the parties with respect to the subject matter hereof superseding all prior written or oral agreements.
(f) Amendments. No amendment or addition to this Agreement shall be deemed effective unless agreed to in writing by the parties hereto.
(g) Right to Specific Performance. The Seller agrees that the Company shall be entitled to a decree of specific performance of the terms hereof or an injunction restraining violation of this Agreement, said right to be in addition to any other remedies available to the Company.
(h) Severability. If any provision of this Agreement is held by a court to be invalid, void or unenforceable, the remaining provisions shall nevertheless continue in full force and effect without being impaired or invalidated in any way and shall be construed in accordance with the purposes and tenor and effect of this Agreement.
(i) Counterparts. This Agreement may be executed in counterparts, each of which shall be an original, but all of which together shall constitute one instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.
[Remainder of page intentionally left blank]
| 3 |
IN WITNESS WHEREOF, the parties hereto have executed this Asset Purchase Agreement as of the date first above written.
| SELLER | COMPANY | |||
| AETERNUM HEALTH, INC | MANASLU LLC | |||
| By: | /s/ Paul Mann | By: | /s/ Andrey Dergo | |
| Address: | 601 Pennsylvania Avenue, NW | Address: | 5th Floor, Anderson Square Building | |
| South Building, Suite 900, | 64 Sheddon Road | |||
| Washington, DC 20004 | PO Box 31325 | |||
| Grand Cayman KY1-1206 | ||||
| Cayman Islands |
EXHIBIT A
BILL OF SALE AND ASSIGNMENT AGREEMENT
In consideration of the issuance of capital shares of Aeternum Health, Inc., a Delaware corporation (the “Company”), the receipt and sufficiency of which are hereby acknowledged, Manaslu LLC (“Transferor”) does hereby sell, convey, assign, transfer, vest and deliver to the Company, its successors and assigns, all of his rights, title, and interest in and to the asset as more particularly defined in Appendix I hereto (the “Assets”), and the Company does hereby acknowledge the receipt of and accept delivery of the Assets.
This Bill of Sale shall be governed by and construed in accordance with the internal laws of the State of Delaware regardless of the laws that might otherwise govern under principles of conflict of laws applicable thereto.
Transferor warrants that he is the owner of the Assets and has the right to enter into and perform each of the acts and obligations described in this Bill of Sale without violating any rights of any third party. The Company acknowledges and agrees that it is taking possession and ownership of the Assets in their “AS IS WHERE IS” condition and that if any portions of the Assets are found defective by the Company, Transferor shall have no obligation to remedy such defects nor any other liability or obligation with respect thereto. TRANSFEROR MAKES AND THE COMPANY OR ANY THIRD PARTY RECEIVES NO WARRANTY, EXPRESSED OR IMPLIED, AND EXPRESSLY EXCLUDES ALL WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. TRANSFEROR SHALL HAVE NO LIABILITY OF ANY NATURE, INCLUDING THOSE OBLIGATIONS UNDER THIS AGREEMENT, FOR CONSEQUENTIAL, EXEMPLARY, OR INCIDENTAL DAMAGES EVEN IF IT HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THE STATED INDEMNITY IS IN LIEU OF ALL LIABILITIES OR OBLIGATIONS OF TRANSFEROR FOR DAMAGES ARISING OUT OF OR IN CONNECTION WITH THE DELIVERY, USE, SALE, OWNERSHIP, OR PERFORMANCE OF THE ASSETS.
IN WITNESS WHEREOF, the Company and Transferor have executed this Bill of Sale effective as of first above day written.
| TRANSFEROR | COMPANY | |||
| MANASLU LLC | AETERNUM HEALTH, INC. | |||
| By: | By: | |||
| xxxxx | xxxxxx | |||
APPENDIX I
COPY OF CALL OPTION
Exhibit 99.1
Aeternum Announces Acquisition of an Option to Acquire 51% of American Renaissance Minerals, Sponsor of the Nkamouna Cobalt-Nickel-Manganese Project in Cameroon
| ● | American Renaissance Minerals, a dedicated vehicle owned by US natural resources private equity firm American Renaissance Resources, is advancing the Nkamouna Cobalt-Nickel-Manganese Project in Cameroon, and is working with the Government of Cameroon toward the award of a new mining permit over the project, free of prior encumbrance. |
| ● | Nickel and cobalt are both designated critical minerals by the United States, which imports approximately three quarters of the cobalt it consumes and, excluding recycled material, is almost wholly reliant on imports for its nickel supply. |
| ● | ARM’s development of Nkamouna is supported by the advocacy program of the United States Government, and the project is regarded as being of strategic interest to the United States, both in national security terms and as a matter of economic and supply-chain interest. |
| ● | Significant capital has been invested in Nkamouna to date, including feasibility-level engineering, metallurgical testwork and environmental and social studies, providing a substantial technical base from which to restart the project. |
| ● | Aeternum Resources will contribute capital and engineering expertise to the development of the project. |
| ● | In January 2026, ARM licensed the entirety of the historical technical information relating to Nkamouna from Geovic Ltd, the majority owner of the prior permit holder, on terms under which Geovic will release all claims in respect of the project. |
| ● | The project will be developed in accordance with Cameroon’s Mining Code of December 2023, including the 10% free-carried interest of the State, with a concentrator at the mine site producing an exportable cobalt-nickel-manganese concentrate rather than shipping unprocessed ore. |
Washington D.C. – August 7, 2026 — Aeternum (OTC: AETN) (“Company”), a company aiming to become a highly strategic supplier of critical minerals, today announced that it has acquired an option to acquire a 51% stake in American Renaissance Minerals (“ARM”). ARM, a dedicated vehicle owned by US natural resources private equity firm American Renaissance Resources, is advancing the Nkamouna Cobalt-Nickel-Manganese Project in Cameroon. The project is aligned with the Company’s objective of becoming a significant supplier of critical minerals to the United States and its allies.
Nkamouna is one of the largest undeveloped cobalt-nickel-manganese projects globally. The project was fully permitted between 2003 and 2025 by Geovic Cameroon Plc, majority owned by Geovic Ltd. A lack of funding, and a permit approaching expiration, meant that Geovic was no longer able to pursue the project, and the permit was withdrawn in February 2025. ARM is working with the Government of Cameroon, including the Ministry of Mines, Industry and Technological Development and the Société Nationale des Mines, toward the award of a new mining permit, free of prior encumbrance, and is able to draw on the whole of the technical work already completed on the project. The large mining area covers approximately 1,650 km2, with an open-cut mining pit envisaged. ARM, in conjunction with Aeternum, intends to construct a concentrator at the mine site, similar in design to the plant that Aeternum is constructing in Nigeria, which is expected to be completed during 4Q 2026. Aeternum will contribute capital and engineering expertise to the development of the project, which is expected to shorten the path from study to production and to reduce execution risk.
In January 2026, ARM entered into an agreement with Geovic Ltd., the majority owner of Geovic Cameroon Plc, the prior holder of the Nkamouna permit, under which ARM licensed the whole of the historical technical information relating to the project, including the geological database, feasibility study, metallurgical testwork and environmental and social baseline studies. Under that agreement, Geovic will release all claims in respect of Nkamouna. The release of those claims removes the legacy exposure associated with the previous permit and allows a new permit to be issued free of prior encumbrance, while the licence preserves for the project the benefit of three decades of technical work already carried out in Cameroon.
The project will be developed in accordance with Cameroon’s Mining Code of December 2023, including the 10% free-carried interest of the State held through the Société Nationale des Mines. ARM and Aeternum intend to construct a concentrator at the mine site, producing an exportable cobalt-nickel-manganese concentrate rather than shipping unprocessed ore, so that the first stage of processing and its associated value are retained in Cameroon. The project is expected to support Cameroonian employment, technical training and local supplier development, together with programs for the communities in the project area, and ARM intends to develop it in partnership with Cameroonian shareholders and management.
Historical Mineral Resource Estimate
Nkamouna has been the subject of extensive historical technical work, including a feasibility study and an independent technical report. That report set out a historical estimate of 323 million tonnes grading 0.21% cobalt, 0.61% nickel and 1.26% manganese across the measured, indicated and inferred categories, of which approximately 121 million tonnes was classified as measured and indicated at grades of 0.23% cobalt, 0.65% nickel and 1.35% manganese. The historical estimate was prepared by a prior owner and was not prepared in accordance with subpart 1300 of Regulation S-K. A qualified person has not undertaken sufficient work to classify the historical estimate as a current mineral resource estimate, and neither the Company nor ARM is treating the historical estimate as a current mineral resource estimate. No assurance is given that the historical estimate will be confirmed by further work. It is presented in order to describe the technical base from which the Company and ARM intend to advance the project.
Nickel and Cobalt End Uses
Nickel is used principally in austenitic stainless steel, which accounts for approximately 65% of nickel consumption in the Western world, and in nickel-based superalloys and non-ferrous alloys, which account for a further 12% and are used in jet engine turbine blades and discs, land-based gas turbines and other high-temperature applications. The balance is used in alloy steels, electroplating, catalysts, chemicals and rechargeable batteries. Nickel is the largest metallic input by mass in nickel-manganese-cobalt lithium-ion cathodes, and battery applications are the fastest growing segment of nickel demand.
Cobalt is used in lithium-ion battery cathodes, where it improves thermal stability, cycle life and energy density, and in superalloys for aerospace and defense applications, which account for approximately half of United States cobalt consumption. Further applications include cemented carbides and cutting tools, catalysts used in petroleum refining and desulfurization, permanent magnets and pigments.
Supply and Demand Dynamics
Supply of both metals is highly concentrated. The Democratic Republic of the Congo accounted for approximately three quarters of world mined cobalt production in 2024, and China is the world’s leading producer of refined cobalt, most of which is produced from partially refined material imported from the Democratic Republic of the Congo. A material proportion of Congolese cobalt is produced artisanally, with associated labor and environmental concerns and limited chain-of-custody traceability, and this material is frequently blended with industrially mined production. Primary nickel supply has become similarly concentrated, with Indonesia now the dominant source of new supply and a significant proportion of that capacity Chinese-owned or Chinese-financed.
Independent forecasters expect demand for both metals to continue to grow, driven by electrification, grid-scale energy storage, aerospace and defense procurement and, more recently, the buildout of data center and artificial intelligence infrastructure. Existing mines are not expected to be able to expand capacity sufficiently to meet that demand, and the pipeline of exploration and development projects outside Chinese-influenced supply chains remains limited.
Strategic Importance to the United States
Nickel and cobalt are both included on the United States list of critical minerals. Net import reliance for cobalt has been approximately 76% in recent years, and the United States has only one operating nickel mine, with the result that, excluding recycled material, the United States would be almost wholly reliant on imports for its nickel supply. Both metals are essential to defense platforms, aerospace propulsion and energy storage, and the concentration of mine supply and refining capacity in a small number of jurisdictions presents a supply chain risk that has become an increasing policy concern for the United States and other Western governments.
Consistent with the strategy announced on August 4, 2026, the Company intends to develop Nkamouna to supply customers in the United States with traceable, responsibly produced units of cobalt, nickel and manganese for United States and allied supply chains.
ARM’s development of Nkamouna is supported by the advocacy program of the United States Government, through which United States agencies support United States commercial interests pursuing strategically significant projects overseas, and the project is regarded as being of strategic interest to the United States, both in national security terms and as a matter of economic and supply-chain interest. Support under that program does not constitute an endorsement of the Company, of ARM or of the transaction described in this release. The Company and ARM regard the project as being of equal importance to Cameroon, as a source of employment, public revenue, in-country processing capacity and long-term partnership between the two countries.
“Nkamouna is precisely the kind of asset our strategy was built for. It is a large, well-characterized critical minerals resource that has absorbed three decades of technical work, and has never been brought into production”, said Josua Oosthuizen, Chief Executive Officer of Aeternum Resources. “Our team has spent the past year designing, manufacturing and installing a gravity separation plant for our Nigerian project. That capability, engineering and construction discipline applied to African orebodies, is what Nkamouna needs to move from study to production, and it is why we believe the combination of the two teams can materially shorten the path to first output”.
“Aeternum brings plant delivery and operating capability to Nkamouna at exactly the point in the project’s life where it is most needed”, said a spokesperson for American Renaissance Minerals. “With Geovic’s historical claims resolved and our work with the Government of Cameroon on the award of a new and unencumbered mining permit well advanced, this partnership gives the project a credible route to development and to supplying cobalt, nickel and manganese into United States supply chains”.
Transaction Details
The Option was acquired from Manaslu LLC, for 50,000,000 shares of common stock and 2,000,000 shares of Series B preferred stock, each share of which has the voting power of 40 shares of common stock.
ABOUT AETERNUM
Aeternum (OTC: AETN) seeks to become a highly strategic supplier of critical minerals. Its first resource is a mine located in the Jos Plateau in Nigeria that will focus on the production of tin, niobium, tantalum and other metals.
Led by a management team with a track record of designing, building and commissioning mineral-processing plants in Africa, and supported by independent geological and metallurgical consultants, Aeternum’s goal is to develop multiple assets globally and create a diversified revenue stream from several critical minerals
FORWARD LOOKING STATEMENTS
This press release contains forward-looking statements that are subject to various risks and uncertainties. These forward-looking statements include statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential,” or other similar expressions. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results. Such factors include, among others, risks relating to the timing and ability of the Company to obtain and the timing of the approval of relevant regulatory bodies, if at all; risks relating to property interests; risks related to access to the project; risks inherent in mineral exploration, including the fact that any particular phase of exploration may be unsuccessful; the availability of contractors; geo-political risks; the global economic climate; metal prices; environmental risks; political risks; and community and non-governmental actions. Further to this, geological similarities or characteristics are not guarantees or certainties of successful exploration. Neither the Company nor any other person assumes responsibility for the accuracy and completeness of any such forward-looking statements. The Company does not undertake, and assumes no obligation, to update or revise any such forward-looking statements or forward-looking information contained herein to reflect new events or circumstances, except as may be required by law. The Company encourage readers to review the “Risk Factors” in our Form 8-K filed July 7, 2026, and other filings with the Securities and Exchange Commission for a comprehensive understanding.
For more information, please contact:
Aeternum
Investor Relations Department